CO6362008A2 - Compuestos n- sulfonamido pirazolil policiclicos - Google Patents
Compuestos n- sulfonamido pirazolil policiclicosInfo
- Publication number
- CO6362008A2 CO6362008A2 CO11039494A CO11039494A CO6362008A2 CO 6362008 A2 CO6362008 A2 CO 6362008A2 CO 11039494 A CO11039494 A CO 11039494A CO 11039494 A CO11039494 A CO 11039494A CO 6362008 A2 CO6362008 A2 CO 6362008A2
- Authority
- CO
- Colombia
- Prior art keywords
- compounds
- pirazolil
- polyclic
- sulfonamide
- formulas
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 229940124530 sulfonamide Drugs 0.000 title 1
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 208000010877 cognitive disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/14—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/18—Bridged systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9479908P | 2008-09-05 | 2008-09-05 | |
| US9924108P | 2008-09-23 | 2008-09-23 | |
| US17327809P | 2009-04-28 | 2009-04-28 | |
| US22653209P | 2009-07-17 | 2009-07-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6362008A2 true CO6362008A2 (es) | 2012-01-20 |
Family
ID=41258775
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO11039494A CO6362008A2 (es) | 2008-09-05 | 2011-03-31 | Compuestos n- sulfonamido pirazolil policiclicos |
Country Status (20)
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2009289649B2 (en) | 2008-09-03 | 2016-05-05 | Biomarin Pharmaceutical Inc. | Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors |
| US8283358B2 (en) | 2008-09-05 | 2012-10-09 | Elan Pharmaceuticals, Inc. | N-sulfonamido polycyclic pyrazolyl compounds |
| US8957066B2 (en) | 2011-02-28 | 2015-02-17 | Biomarin Pharmaceutical Inc. | Histone deacetylase inhibitors |
| US10059723B2 (en) | 2011-02-28 | 2018-08-28 | Biomarin Pharmaceutical Inc. | Histone deacetylase inhibitors |
| WO2012118782A1 (en) | 2011-02-28 | 2012-09-07 | Repligen Corporation | Histone deacetylase inhibitors |
| RU2665554C2 (ru) | 2013-03-15 | 2018-08-31 | Байомарин Фармасьютикал Инк. | Ингибиторы hdac |
| EP4084797A4 (en) * | 2020-01-03 | 2024-02-21 | Blue Oak Pharmaceuticals, Inc. | COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISEASES |
| CN111909217B (zh) * | 2020-08-20 | 2023-05-02 | 昆明贵金属研究所 | 一种双(二叔丁基-4-二甲氨基苯基膦)四溴双钯(ⅱ)化合物及其制备方法和用途 |
| CN115448892B (zh) * | 2022-09-19 | 2023-07-07 | 郑州铁路职业技术学院 | 一种苯并噻二唑杂环化合物的合成方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8727989D0 (en) * | 1987-11-30 | 1988-01-06 | Merck Sharp & Dohme | Therapeutic agents |
| EP0330788A1 (en) | 1988-03-01 | 1989-09-06 | Merrell Dow Pharmaceuticals Inc. | Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of cardiac arrhythmia |
| WO2005113542A2 (en) | 2004-05-20 | 2005-12-01 | Elan Pharmaceuticals, Inc. | N-cyclic sulfonamido inhibitors of gamma secretase |
| JP2009504773A (ja) * | 2005-08-19 | 2009-02-05 | エラン ファーマシューティカルズ,インコーポレイテッド | ガンマセクレターゼの架橋n−二環式スルホンアミド阻害剤 |
| TW200813054A (en) | 2006-06-02 | 2008-03-16 | Elan Pharm Inc | Fused, tricyclic sulfonamide inhibitors of gamma secretase |
| CN101128035B (zh) | 2006-08-18 | 2011-08-24 | 中兴通讯股份有限公司 | 时分码分多址系统中信道间的定时方法 |
| MX2009012525A (es) * | 2007-05-25 | 2009-12-09 | Elan Pharm Inc | Pirazol-pirrolidinas como inhibidores de gamma secretasa. |
| US8283358B2 (en) | 2008-09-05 | 2012-10-09 | Elan Pharmaceuticals, Inc. | N-sulfonamido polycyclic pyrazolyl compounds |
-
2009
- 2009-09-04 US US12/554,134 patent/US8283358B2/en not_active Expired - Fee Related
- 2009-09-04 EA EA201170421A patent/EA201170421A1/ru unknown
- 2009-09-04 TW TW098129931A patent/TW201014856A/zh unknown
- 2009-09-04 AR ARP090103413A patent/AR073497A1/es not_active Application Discontinuation
- 2009-09-04 AU AU2009289579A patent/AU2009289579A1/en not_active Abandoned
- 2009-09-04 CN CN2009801426386A patent/CN102203089A/zh active Pending
- 2009-09-04 BR BRPI0918213A patent/BRPI0918213A2/pt not_active IP Right Cessation
- 2009-09-04 WO PCT/US2009/055987 patent/WO2010028213A2/en not_active Ceased
- 2009-09-04 EP EP09792258A patent/EP2346863A2/en not_active Withdrawn
- 2009-09-04 PE PE2011000438A patent/PE20110418A1/es not_active Application Discontinuation
- 2009-09-04 CA CA2736767A patent/CA2736767A1/en not_active Abandoned
- 2009-09-04 MX MX2011002047A patent/MX2011002047A/es unknown
- 2009-09-04 JP JP2011526217A patent/JP2012502051A/ja active Pending
- 2009-09-04 KR KR1020117007863A patent/KR20110055715A/ko not_active Withdrawn
-
2011
- 2011-02-17 IL IL211263A patent/IL211263A0/en unknown
- 2011-02-24 CL CL2011000405A patent/CL2011000405A1/es unknown
- 2011-03-16 ZA ZA2011/01994A patent/ZA201101994B/en unknown
- 2011-03-31 CO CO11039494A patent/CO6362008A2/es not_active Application Discontinuation
- 2011-04-01 MA MA33737A patent/MA32688B1/fr unknown
- 2011-04-01 EC EC2011010947A patent/ECSP11010947A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2346863A2 (en) | 2011-07-27 |
| IL211263A0 (en) | 2011-04-28 |
| US20100081680A1 (en) | 2010-04-01 |
| KR20110055715A (ko) | 2011-05-25 |
| EA201170421A1 (ru) | 2012-01-30 |
| ECSP11010947A (es) | 2011-07-29 |
| BRPI0918213A2 (pt) | 2015-12-08 |
| MX2011002047A (es) | 2011-06-17 |
| AU2009289579A1 (en) | 2010-03-11 |
| AR073497A1 (es) | 2010-11-10 |
| TW201014856A (en) | 2010-04-16 |
| WO2010028213A2 (en) | 2010-03-11 |
| US8283358B2 (en) | 2012-10-09 |
| PE20110418A1 (es) | 2011-06-22 |
| ZA201101994B (en) | 2011-11-30 |
| CN102203089A (zh) | 2011-09-28 |
| CL2011000405A1 (es) | 2011-07-01 |
| MA32688B1 (fr) | 2011-10-02 |
| WO2010028213A3 (en) | 2010-06-03 |
| CA2736767A1 (en) | 2010-03-11 |
| JP2012502051A (ja) | 2012-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR20130339A (es) | Nuevos derivados heterocíclicos y su uso en el tratamiento de desordenes neurológicos | |
| ECSP11010947A (es) | Compuestos n- sulfonamido pirazolil policíclicos | |
| CR10387A (es) | Derivados de 6,7,8,9-tetrahidro-5h-pirimido[4,5-d]azepin-4-il] amina como moduladores del potencial transitorio de receptor vaillinoide 1 para el tratamiento de dolor | |
| ECSP11011067A (es) | Compuestos para el tratamiento de enfermedades y desórdenes oftalmológicos | |
| DOP2011000135A (es) | Moduladores de aril metil benzoquinazolinona alostericos positivos del receptor m1 | |
| MX336549B (es) | Compuestos de 2-amino-4-ariltiazol como antagonistas de trpa1. | |
| NI201200107A (es) | Moduladores alostéricos positivos de receptores m1 de la quinolina amida | |
| UY33277A (es) | Compuestos de anillo espiro-tetraciclico como moduladores de beta-secretasa y métodos de uso | |
| DOP2011000010A (es) | Derivados de triazol utiles para el tratamiento de enfermedades | |
| CL2011000144A1 (es) | Compuestos derivados de benzo (1,4) dioxin-2-ilmetil-sulfamida; composiciones farmaceuticas que los contienen; proceso para prepararlos y uso en el tratamiento de la ansiedad, epilepsia, dolor, abuso de sustancias, trastornos relacionados, entre otros. | |
| ECSP066701A (es) | Derivados de sulfonamida para el tratamiento de enfermedades | |
| ECSP11011051A (es) | Nuevos compuestos 578 | |
| GB2511685A (en) | Muscarinic m1 receptor agonists | |
| UY30220A1 (es) | Compuestos de tetrahidropiridotienopirimidina y metodos para su empleo | |
| CO6501188A2 (es) | Moduladores de piranil aril metil benzoquinazolina alostéricos positivos del receptos m1 | |
| PA8622001A1 (es) | Derivados de sulfonamida para el tratamiento de enfermedades | |
| PA8604201A1 (es) | Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades | |
| ECSP11010956A (es) | Compuestos enlazados con azufre para el tratamiento de enfermedades y trastornos oftalmicos | |
| UY32744A (es) | Derivados de 2-carboxamida-7-piperazinil-benzofurano 774 | |
| PA8603001A1 (es) | Compuestos utiles para el tratamiento de enfermedades | |
| PA8627001A1 (es) | Compuestos para el tratamiento de enfermedades | |
| CR8636A (es) | Compuestos utiles para el tratamiento de enfermedades | |
| HK1160138A (en) | N-sulfonamido polycyclic pyrazolyl compounds | |
| GT200500056A (es) | Compuestos utiles para el tratamiento de enfermedades | |
| CR8514A (es) | Derivados de sulfonamida para el tratamiento de enfermedades |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Application refused |